Australia markets close in 4 hours 40 minutes

Unity Biotechnology, Inc. (UBX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.9100-0.2800 (-5.39%)
At close: 4:00PM EDT

4.8000 -0.11 (-2.24%)
After hours: 5:53PM EDT

Currency in USD

Valuation measures

Market cap (intra-day) 5268.57M
Enterprise value 3249.69M
Trailing P/E N/A
Forward P/E 1-4.06
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)3.16
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 7-2.90

Trading information

Stock price history

Beta (5Y monthly) 0.29
52-week change 3-19.16%
S&P500 52-week change 352.13%
52-week high 315.4400
52-week low 32.7200
50-day moving average 36.3260
200-day moving average 35.8081

Share statistics

Avg vol (3-month) 3684.48k
Avg vol (10-day) 3394.47k
Shares outstanding 554.7M
Implied shares outstanding 6N/A
Float 42.58M
% held by insiders 18.73%
% held by institutions 158.97%
Shares short (30 Mar 2021) 42.03M
Short ratio (30 Mar 2021) 43.95
Short % of float (30 Mar 2021) 45.31%
Short % of shares outstanding (30 Mar 2021) 43.71%
Shares short (prior month 25 Feb 2021) 42.12M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-36.39%
Return on equity (ttm)-92.19%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-65.81M
EBITDA -86.08M
Net income avi to common (ttm)-93.84M
Diluted EPS (ttm)-1.8450
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)97.7M
Total cash per share (mrq)1.79
Total debt (mrq)63.5M
Total debt/equity (mrq)76.61
Current ratio (mrq)6.97
Book value per share (mrq)1.56

Cash flow statement

Operating cash flow (ttm)-78.33M
Levered free cash flow (ttm)-47.06M